1. Long-Term Prognosis Among 1-Year Survivors of Ex Vivo T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation: A Landmark Analysis 
Christina Cho, MD, Meier Hsu, MS, Scott Avecilla, MD, PhD, Pere Barba, PhD, Juliet N. Barker, MBBS, Hugo Castro-Malaspina, MD, Sean M. Devlin, PhD, Sergio A. Giralt, MD, Ann A. Jakubowski, PhD, MD, Guenther Koehne, MD, PhD, Richard Meagher, PhD, Richard J. O'Reilly, MD, Esperanza Papadopoulos, MD, Doris M. Ponce, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, FACP, Miguel-Angel Perales, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S84-S85 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Causes of Death among Recipients of TCD HCT Alive and Relapse Free at 1 Year Landmark.
Biology of Blood and Marrow Transplantation  , S84-S85DOI: ( /j.bbmt )
Copyright © Terms and Conditions